Tags |
|
|
Links |
|
|
Your Space - How I Stuffed Up Big Time
Now BQT (ASX Code) was a stock that I have owned in the past around 18 months ago, and was responsible for one of my biggest losses. The loss was about 45%.
The reason for th
The reason for th
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
is confession is so YOU can learn by my mistakes and it also reminds me not to get caught again. Here is the account of what eventuated.
BQT was the “flavor of the month.” It
BQT was the “flavor of the month.” It
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
was being promoted (ramped) at a chat site.
Everything sounded wonderful, good company announcements came out which were blown out of all proportion. So I dived in to get som
Everything sounded wonderful, good company announcements came out which were blown out of all proportion. So I dived in to get som
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
e and couldn’t because every time that I put a bid in I would miss out as the share price was rising too fast ,and the information that I was getting was 20 minutes old.
This
This
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
chasing the share price went on for at least an hour during which I was panicking and I was becoming frightened of missing out.
The final result was I paid top price for the
The final result was I paid top price for the
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
stock which had risen over 35% on the opening share price that morning.
The amount that I had invested was just over $1,000. The market closed and I felt very satisfied that
The amount that I had invested was just over $1,000. The market closed and I felt very satisfied that
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
had managed to buy in. All I had to do now was to sit back and wait for the enormous profits to come rolling in.
What I did not realize was that I was a “Mug Punter” who had
What I did not realize was that I was a “Mug Punter” who had
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
been involved in a “Pump and Dump” There are several versions of this about, (Read previous article)
Next morning as soon as the market opened, I was waiting for the share p
Next morning as soon as the market opened, I was waiting for the share p
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ice. (20 minute delay) To my horror the share price had dropped by 25% on opening. Truck loads of stock were being sold off by the profit takers who had bought in much cheaper
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
in the days before I did.
What did I do? (This was the days before I knew what a stop loss was) I held on, telling myself (conning) that it was only a correction and that th
What did I do? (This was the days before I knew what a stop loss was) I held on, telling myself (conning) that it was only a correction and that th
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
share price would start to go up again soon.
Did it? Like hell! The share price continued to recede to around a 50% loss as more stock was sold off.
Rather than sell then,
Did it? Like hell! The share price continued to recede to around a 50% loss as more stock was sold off.
Rather than sell then,
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
as I was too scared to take a big loss and admit to myself that I was wrong. I decided to place it in my new “Long Term” portfolio and wait till the share price went up.
It s
It s
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ayed there for another 6 months during which it hardly moved at all. During that time I saw opportunities come and go, by which I could have recuperated the loss quite easily
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
had I sold. But I could not face up to the loss.
I did sell eventually, and used that loss to offset some capital gains I was fortunate to make. Just after I had plucked up c
I did sell eventually, and used that loss to offset some capital gains I was fortunate to make. Just after I had plucked up c
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
urage to sell BQT it dropped down even further. So I was fortunate to get out when I did. And brother did I feel better.
The lessons learnt were:-
1. Don’t chase share price
The lessons learnt were:-
1. Don’t chase share price
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s.
2. Have a stop loss in place. (Always)
3. Most important Do Your OWN research. Don’t believe all you hear.
4. Watch out for PANIC and GREED .We all suffer from these emo
2. Have a stop loss in place. (Always)
3. Most important Do Your OWN research. Don’t believe all you hear.
4. Watch out for PANIC and GREED .We all suffer from these emo
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ions occasionally.
5. If it sounds too good to be true it usually is. (Back to step 3.)
6. Always be aware of traps in trading. There are sharks out there who are experts in
5. If it sounds too good to be true it usually is. (Back to step 3.)
6. Always be aware of traps in trading. There are sharks out there who are experts in
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
pumping and dumping and eating you up and your money too.
7. Get “real time” data. You can see what is happening NOW! I personally use E-trade. But there are others equally
7. Get “real time” data. You can see what is happening NOW! I personally use E-trade. But there are others equally
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ood around.
8. Just because it looks good, doesn’t mean it is. (Go back to step 3.)
Incidentally I now own BQT again, which I bought back at a considerably lower price than
8. Just because it looks good, doesn’t mean it is. (Go back to step 3.)
Incidentally I now own BQT again, which I bought back at a considerably lower price than
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
what I sold them for.
But I still like the basic fundamentals of the company BUT they are definitely long term as they are an emerging company. OR am I conning myself again??
But I still like the basic fundamentals of the company BUT they are definitely long term as they are an emerging company. OR am I conning myself again??
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.yourspace.org.ua/article/116803/yourspace-How-I-Stuffed-Up-Big-Time.html">How I Stuffed Up Big Time</a>
BB link (for phorums):
[url=http://www.yourspace.org.ua/article/116803/yourspace-How-I-Stuffed-Up-Big-Time.html]How I Stuffed Up Big Time[/url]
Related Articles:
Top 7 Tips for Business Newsletters
Forums and Guestbooks - Are They Right For Your Website?
No Credit Car Loans - Car Loan Approval with No Credit History
Bookmark it:
|